Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

2.

Management of Invasive Fungal Infections in Adult Patients with Hematological Malignancies in Greece during the Financial Crisis: Challenges and Recommendations.

Sipsas NV, Pagoni MN, Kofteridis DP, Meletiadis J, Vrioni G, Papaioannou M, Antoniadou A, Petrikkos G, Samonis G.

J Fungi (Basel). 2018 Aug 9;4(3). pii: E94. doi: 10.3390/jof4030094.

3.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

4.

Recent Advances in the Pathogenesis of Mucormycoses.

Petrikkos G, Tsioutis C.

Clin Ther. 2018 Jun;40(6):894-902. doi: 10.1016/j.clinthera.2018.03.009. Epub 2018 Apr 6. Review.

PMID:
29631910
5.

Challenges in the diagnosis and treatment of mucormycosis.

Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G.

Med Mycol. 2018 Apr 1;56(suppl_1):93-101. doi: 10.1093/mmy/myx101. Review.

6.

Fungal infections in patients with inflammatory bowel disease: A systematic review.

Stamatiades GA, Ioannou P, Petrikkos G, Tsioutis C.

Mycoses. 2018 Jun;61(6):366-376. doi: 10.1111/myc.12753. Epub 2018 Mar 25. Review.

7.

Association Between Candiduria and Candidemia: A Clinical and Molecular Analysis of Cases.

Drogari-Apiranthitou M, Anyfantis I, Galani I, Kanioura L, Daikos GL, Petrikkos G.

Mycopathologia. 2017 Dec;182(11-12):1045-1052. doi: 10.1007/s11046-017-0180-2. Epub 2017 Jul 25.

PMID:
28744769
8.

Reduction of Environmental Contamination With Multidrug-Resistant Bacteria by Copper-Alloy Coating of Surfaces in a Highly Endemic Setting.

Souli M, Antoniadou A, Katsarolis I, Mavrou I, Paramythiotou E, Papadomichelakis E, Drogari-Apiranthitou M, Panagea T, Giamarellou H, Petrikkos G, Armaganidis A.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):765-771. doi: 10.1017/ice.2017.52. Epub 2017 May 5.

PMID:
28473010
9.

A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.

Risslegger B, Zoran T, Lackner M, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Houbraken J, Uzun O, Edlinger M, Fuente S, Lass-Flörl C.

Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13.

10.

Complicated Lemierre Syndrome Caused by Streptococcus gordonii and Possible Rickettsial Co-Infection in a Patient with Thrombophilia Predisposition.

Ioannou A, Dimitriou D, Dimitriou P, Katsios A, Petrikkos G.

Eur J Case Rep Intern Med. 2017 Mar 17;4(5):000606. doi: 10.12890/2017_000606. eCollection 2017.

11.

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.

Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, Lass-Flörl C, Calandra T, Viscoli C, Herbrecht R.

Haematologica. 2017 Mar;102(3):433-444. doi: 10.3324/haematol.2016.152900. Epub 2016 Dec 23.

12.

Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat.

Margaritis A, Galani I, Chatzikonstantinou M, Petrikkos G, Souli M.

J Med Microbiol. 2017 Mar;66(3):266-275. doi: 10.1099/jmm.0.000397. Epub 2017 Mar 20.

PMID:
27902429
13.

Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.

Pana ZD, Seidel D, Skiada A, Groll AH, Petrikkos G, Cornely OA, Roilides E; Collaborators of Zygomyco.net and/or FungiScope™ Registries*.

BMC Infect Dis. 2016 Nov 10;16(1):667.

14.

Emergence of Klebsiella pneumoniae co-producing OXA-48, CTX-M-15, and ArmA in Greece.

Galani I, Anagnostoulis G, Chatzikonstantinou M, Petrikkos G, Souli M.

Clin Microbiol Infect. 2016 Oct;22(10):898-899. doi: 10.1016/j.cmi.2016.08.002. Epub 2016 Aug 17. No abstract available.

15.

Diagnostic value of a semi-nested PCR for the diagnosis of mucormycosis and aspergillosis from paraffin-embedded tissue: A single center experience.

Drogari-Apiranthitou M, Panayiotides I, Galani I, Konstantoudakis S, Arvanitidis G, Spathis A, Gouloumi AR, Tsakiraki Z, Tsiodras S, Petrikkos G.

Pathol Res Pract. 2016 May;212(5):393-7. doi: 10.1016/j.prp.2016.02.010. Epub 2016 Feb 2.

PMID:
26874574
16.

The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study.

Dautzenberg MJ, Wekesa AN, Gniadkowski M, Antoniadou A, Giamarellou H, Petrikkos GL, Skiada A, Brun-Buisson C, Bonten MJ, Derde LP; Mastering hOSpital Antimicrobial Resistance in Europe Work Package 3 Study Team.

Crit Care Med. 2015 Jun;43(6):1170-7. doi: 10.1097/CCM.0000000000001028.

17.

Development of new strategies for early diagnosis of mucormycosis from bench to bedside.

Walsh TJ, Skiada A, Cornely OA, Roilides E, Ibrahim A, Zaoutis T, Groll A, Lortholary O, Kontoyiannis DP, Petrikkos G.

Mycoses. 2014 Dec;57 Suppl 3:2-7. doi: 10.1111/myc.12249.

18.

Imported lymphocutaneous sporotrichosis in Greece.

Xirotagaros G, Drogari-Apiranthitou M, Panayiotides IG, Tsakiraki Z, Tsamakis C, Theotokoglou S, Tofas P, van Diepeningen AD, de Hoog GS, Petrikkos G, Rigopoulos D.

Br J Dermatol. 2015 Jul;173(1):291-3. doi: 10.1111/bjd.13558. Epub 2015 May 12. No abstract available.

PMID:
25421871
19.

Rhodotorula mucilaginosa associacted meningitis: A subacute entity with high mortality. Case report and review.

Tsiodras S, Papageorgiou S, Meletiadis J, Tofas P, Pappa V, Panayiotides J, Karakitsos P, Armaganidis A, Petrikkos G.

Med Mycol Case Rep. 2014 Sep 10;6:46-50. doi: 10.1016/j.mmcr.2014.08.006. eCollection 2014 Oct.

20.

'Prostate Abscess' as the Initial Manifestation of Granulomatosis with Polyangiitis (Wegener's Granulomatosis).

Tsiodras S, Poulakou G, Leventakos K, Panopoulou H, Elezoglou A, Manoloudaki K, Chrisofos M, Petrikkos G, Panayiotides IG.

Urol Int. 2016;96(2):244-6. doi: 10.1159/000363113. Epub 2014 Aug 13.

PMID:
25138619
21.

Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.

Vallianou N, Evangelopoulos A, Hadjisoteriou M, Avlami A, Petrikkos G.

J Chemother. 2015;27(6):319-23. doi: 10.1179/1973947814Y.0000000205. Epub 2014 Aug 11.

PMID:
25112954
22.

Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpoints.

Gamaletsou MN, Daikos GL, Walsh TJ, Perlin DS, Ortigosa CJ, Psaroulaki A, Pagoni M, Argyropoulou A, Nepka M, Perivolioti E, Kotsopoulou M, Perloretzou S, Marangos M, Kofteridis D, Grammatikou M, Goukos D, Petrikkos G, Sipsas NV.

Int J Antimicrob Agents. 2014 Sep;44(3):248-55. doi: 10.1016/j.ijantimicag.2014.05.015. Epub 2014 Jun 30.

PMID:
25108876
23.

Prescription of antibiotics and knowledge about antibiotic costs among physicians working in tertiary-care hospitals.

Maltezou HC, Maltezos E, Antoniadou A, Gourgoulis GM, Katerelos P, Adamis G, Petrikkos G, Gargalianos P.

J Chemother. 2014 Dec;26(6):375-8. doi: 10.1179/1973947813Y.0000000160. Epub 2014 Jan 2.

PMID:
24621168
24.

Risk factors for community-associated methicillin-resistant Staphylococcus aureus colonisation in a large metropolitan area in Greece: An epidemiological study using two case definitions.

Tsiodras S, Daikos GL, Lee A, Plachouras D, Antoniadou A, Ploiarchopoulou F, Psichogiou M, Petrikkos G, Harbarth S.

J Glob Antimicrob Resist. 2014 Mar;2(1):27-33. doi: 10.1016/j.jgar.2013.10.001. Epub 2013 Oct 26.

PMID:
27873634
25.

Action Plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece.

Maltezou HC, Kontopidou F, Dedoukou X, Katerelos P, Gourgoulis GM, Tsonou P, Maragos A, Gargalianos P, Gikas A, Gogos C, Koumis I, Lelekis M, Maltezos E, Margariti G, Nikolaidis P, Pefanis A, Petrikkos G, Syrogiannopoulos G, Tsakris A, Vatopoulos A, Saroglou G, Kremastinou J, Daikos GL; Working Group for the National Action Plan to Combat Infections due to Carbapenem-Resistant, Gram-Negative Pathogens in Acute-Care Hospitals in Greece.

J Glob Antimicrob Resist. 2014 Mar;2(1):11-16. doi: 10.1016/j.jgar.2013.06.002. Epub 2013 Aug 13.

PMID:
27873631
26.

Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.

Galani I, Orlandou K, Moraitou H, Petrikkos G, Souli M.

Int J Antimicrob Agents. 2014 Apr;43(4):370-4. doi: 10.1016/j.ijantimicag.2013.12.010. Epub 2014 Feb 4.

PMID:
24560919
27.

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, Johnson E, Meletiadis J, Pana ZD, Lackner M, Verweij P, Freiberger T, Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Guinea J, Guarro J, de Hoog S, Hope W, Kathuria S, Lortholary O, Meis JF, Ullmann AJ, Petrikkos G, Lass-Flörl C; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology.

Clin Microbiol Infect. 2014 Apr;20 Suppl 3:27-46. doi: 10.1111/1469-0691.12465.

28.

High prevalence of the UGT1A1*28 variant in HIV-infected individuals in Greece.

Panagopoulos P, Paraskevis D, Katsarolis I, Sypsa V, Detsika M, Protopapas K, Antoniadou A, Papadopoulos A, Petrikkos G, Hatzakis A.

Int J STD AIDS. 2014 Oct;25(12):860-5. doi: 10.1177/0956462414523259. Epub 2014 Feb 10.

PMID:
24516079
29.

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.

Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, Arikan-Akdagli S, Akova M, Boekhout T, Caira M, Guinea J, Chakrabarti A, Dannaoui E, van Diepeningen A, Freiberger T, Groll AH, Hope WW, Johnson E, Lackner M, Lagrou K, Lanternier F, Lass-Flörl C, Lortholary O, Meletiadis J, Muñoz P, Pagano L, Petrikkos G, Richardson MD, Roilides E, Skiada A, Tortorano AM, Ullmann AJ, Verweij PE, Cornely OA, Cuenca-Estrella M; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology.

Clin Microbiol Infect. 2014 Apr;20 Suppl 3:47-75. doi: 10.1111/1469-0691.12515.

30.

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Flörl C, Lortholary O, Meis JF, Meletiadis J, Muñoz P, Richardson M, Roilides E, Tortorano AM, Ullmann AJ, van Diepeningen A, Verweij P, Petrikkos G; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology.

Clin Microbiol Infect. 2014 Apr;20 Suppl 3:5-26. doi: 10.1111/1469-0691.12371.

31.

Epidemiology of mucormycosis in Europe.

Petrikkos G, Skiada A, Drogari-Apiranthitou M.

Clin Microbiol Infect. 2014 Jun;20 Suppl 6:67-73. doi: 10.1111/1469-0691.12563. Epub 2014 Mar 6. Review.

32.

Acute microcirculatory effects of medium frequency versus high frequency neuromuscular electrical stimulation in critically ill patients - a pilot study.

Angelopoulos E, Karatzanos E, Dimopoulos S, Mitsiou G, Stefanou C, Patsaki I, Kotanidou A, Routsi C, Petrikkos G, Nanas S.

Ann Intensive Care. 2013 Dec 19;3(1):39. doi: 10.1186/2110-5820-3-39.

33.

Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.

Derde LPG, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJL, Gniadkowski M, Hryniewicz W, Empel J, Dautzenberg MJD, Annane D, Aragão I, Chalfine A, Dumpis U, Esteves F, Giamarellou H, Muzlovic I, Nardi G, Petrikkos GL, Tomic V, Martí AT, Stammet P, Brun-Buisson C, Bonten MJM; MOSAR WP3 Study Team.

Lancet Infect Dis. 2014 Jan;14(1):31-39. doi: 10.1016/S1473-3099(13)70295-0. Epub 2013 Oct 23. Erratum in: Lancet Infect Dis. 2014 Jan;14(1):11.

34.

Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Magri V, Wagenlehner FM, Marras E, VAN Till JW, Houbiers J, Panagopoulos P, Petrikkos GL, Perletti G.

Exp Ther Med. 2013 Aug;6(2):503-508. Epub 2013 Jun 21.

35.

Cutaneous mucormycosis.

Skiada A, Petrikkos G.

Skinmed. 2013 May-Jun;11(3):155-9; quiz 159-60. Review.

PMID:
23930354
36.

Genetic basis of aminoglycoside resistance following changes in aminoglycoside prescription patterns.

Kosmidis C, Giannopoulou M, Flountzi A, Markogiannakis A, Goukos D, Petrikkos G, Daikos GL, Tzanetou K.

J Chemother. 2013 Aug;25(4):217-21. doi: 10.1179/1973947813Y.0000000073.

PMID:
23906075
37.

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.

Gamaletsou MN, Walsh TJ, Zaoutis T, Pagoni M, Kotsopoulou M, Voulgarelis M, Panayiotidis P, Vassilakopoulos T, Angelopoulou MK, Marangos M, Spyridonidis A, Kofteridis D, Pouli A, Sotiropoulos D, Matsouka P, Argyropoulou A, Perloretzou S, Leckerman K, Manaka A, Oikonomopoulos P, Daikos G, Petrikkos G, Sipsas NV.

Clin Microbiol Infect. 2014 Jan;20(1):O50-7. doi: 10.1111/1469-0691.12312. Epub 2013 Jul 24.

38.

Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group.

Levy Hara G, Gould I, Endimiani A, Pardo PR, Daikos G, Hsueh PR, Mehtar S, Petrikkos G, Casellas JM, Daciuk L, Paciel D, Novelli A, Saginur R, Pryluka D, Medina J, Savio E.

J Chemother. 2013 Jun;25(3):129-40. doi: 10.1179/1973947812Y.0000000062.

PMID:
23783137
39.

Comparative evaluation of conventional and real-time PCR assays for detecting Bacteroides fragilis in clinical samples.

Papaparaskevas J, Mela V, Houhoula DP, Pantazatou A, Petrikkos GL, Tsakris A.

J Clin Microbiol. 2013 May;51(5):1593-5. doi: 10.1128/JCM.00449-13. Epub 2013 Feb 27.

40.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.

Lortholary O, Petrikkos G, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Meersseman W, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group.

Clin Microbiol Infect. 2012 Dec;18 Suppl 7:68-77. doi: 10.1111/1469-0691.12042.

41.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Donnelly JP, Garbino J, Groll AH, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Cuenca-Estrella M; ESCMID Fungal Infection Study Group.

Clin Microbiol Infect. 2012 Dec;18 Suppl 7:53-67. doi: 10.1111/1469-0691.12041.

42.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Herbrecht R, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Verweij PE, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group.

Clin Microbiol Infect. 2012 Dec;18 Suppl 7:38-52. doi: 10.1111/1469-0691.12040.

43.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group.

Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37. doi: 10.1111/1469-0691.12039.

44.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Flörl C, Richardson MD, Akova M, Bassetti M, Calandra T, Castagnola E, Cornely OA, Garbino J, Groll AH, Herbrecht R, Hope WW, Kullberg BJ, Lortholary O, Meersseman W, Petrikkos G, Roilides E, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group.

Clin Microbiol Infect. 2012 Dec;18 Suppl 7:9-18. doi: 10.1111/1469-0691.12038.

45.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.

Ullmann AJ, Cornely OA, Donnelly JP, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Cuenca-Estrella M; ESCMID Fungal Infection Study Group.

Clin Microbiol Infect. 2012 Dec;18 Suppl 7:1-8. doi: 10.1111/1469-0691.12037.

46.

Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates.

Souli M, Galani I, Plachouras D, Panagea T, Armaganidis A, Petrikkos G, Giamarellou H.

J Antimicrob Chemother. 2013 Apr;68(4):852-7. doi: 10.1093/jac/dks473. Epub 2012 Dec 9.

PMID:
23228934
47.

Incidence and risk factors for central vascular catheter-related bloodstream infections in a tertiary care hospital.

Tarpatzi A, Avlamis A, Papaparaskevas J, Daikos GL, Stefanou I, Katsandri A, Vasilakopoulou A, Chatzigeorgiou KS, Petrikkos GL.

New Microbiol. 2012 Oct;35(4):429-37. Epub 2012 Oct 1.

48.

Global epidemiology of cutaneous zygomycosis.

Skiada A, Rigopoulos D, Larios G, Petrikkos G, Katsambas A.

Clin Dermatol. 2012 Nov-Dec;30(6):628-32. doi: 10.1016/j.clindermatol.2012.01.010. Review.

PMID:
23068150
49.

Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.

Galani I, Souli M, Daikos GL, Chrysouli Z, Poulakou G, Psichogiou M, Panagea T, Argyropoulou A, Stefanou I, Plakias G, Giamarellou H, Petrikkos G.

J Chemother. 2012 Aug;24(4):191-4. doi: 10.1179/1973947812Y.0000000015.

50.

Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).

Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, Lortholary O, Petrikkos GL; European Conference on Infections in Leukemia.

Haematologica. 2013 Apr;98(4):492-504. doi: 10.3324/haematol.2012.065110. Epub 2012 Sep 14. Review.

Supplemental Content

Loading ...
Support Center